Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • 3149 Real-world Australian exp...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
3149 Real-world Australian experience with Ofatumumab in the MSBase registry

3149 Real-world Australian experience with Ofatumumab in the MSBase registry

Bibliographic Details
Main Authors: Nevin John, Tomas Kalincik, Jeannette Lechner-Scott, Mark Slee, Suzanne Hodgkinson, Tim Spelman, Helmut Butzkueven, Michael Barnett, Allan Kermode, Richard Macdonell, Anneke Van Der Walt, Pamela McCombe, Marzena Fabis-Pedrini, William M Carroll, Margaret Migocki, Birte Schmitt
Format: Article
Language:English
Published: BMJ Publishing Group 2024-08-01
Series:BMJ Neurology Open
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • 010 Real-world experience with ocrelizumab in the MSBase registry – Australian RRMS cohort
    by: Mark Slee, et al.
    Published: (2021-08-01)
  • The MSBase pregnancy, neonatal outcomes, and women’s health registry
    by: Vilija G. Jokubaitis, et al.
    Published: (2021-04-01)
  • Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
    by: Vicki E Maltby, et al.
    Published: (2021-10-01)
  • Comparative efficacy of ofatumumab oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons
    by: Nicholas Riley, et al.
    Published: (2024-03-01)
  • 008 Disease reactivation after cessation of disease-modifying therapy in relapsing-remitting multiple sclerosis
    by: Steve Vucic, et al.
    Published: (2021-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs